Literature DB >> 15029481

Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.

Luc Djoussé1, Beth Knowlton, Michael R Hayden, Elisabeth W Almqvist, Ryan R Brinkman, Christopher A Ross, Russel L Margolis, Adam Rosenblatt, Alexandra Durr, Catherine Dode, Patrick J Morrison, Andrea Novelletto, Marina Frontali, Ronald J A Trent, Elizabeth McCusker, Estrella Gómez-Tortosa, David Mayo Cabrero, Randi Jones, Andrea Zanko, Martha Nance, Ruth K Abramson, Oksana Suchowersky, Jane S Paulsen, Madaline B Harrison, Qiong Yang, L Adrienne Cupples, Jayalakshmi Mysore, James F Gusella, Marcy E MacDonald, Richard H Myers.   

Abstract

Huntington disease (HD) is a neurodegenerative disorder caused by the abnormal expansion of CAG repeats in the HD gene on chromosome 4p16.3. A recent genome scan for genetic modifiers of age at onset of motor symptoms (AO) in HD suggests that one modifier may reside in the region close to the HD gene itself. We used data from 535 HD participants of the New England Huntington cohort and the HD MAPS cohort to assess whether AO was influenced by any of the three markers in the 4p16 region: MSX1 (Drosophila homeo box homologue 1, formerly known as homeo box 7, HOX7), Delta2642 (within the HD coding sequence), and BJ56 ( D4S127). Suggestive evidence for an association was seen between MSX1 alleles and AO, after adjustment for normal CAG repeat, expanded repeat, and their product term (model P value 0.079). Of the variance of AO that was not accounted for by HD and normal CAG repeats, 0.8% could be attributed to the MSX1 genotype. Individuals with MSX1 genotype 3/3 tended to have younger AO. No association was found between Delta2642 (P=0.44) and BJ56 (P=0.73) and AO. This study supports previous studies suggesting that there may be a significant genetic modifier for AO in HD in the 4p16 region. Furthermore, the modifier may be present on both HD and normal chromosomes bearing the 3 allele of the MSX1 marker.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029481      PMCID: PMC1866166          DOI: 10.1007/s10048-004-0175-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  30 in total

1.  A dinucleotide repeat polymorphism at the D4S127 locus.

Authors:  S A Taylor; G T Barnes; M E MacDonald; J F Gusella
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

Review 2.  Homeo boxes in the study of development.

Authors:  W J Gehring
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

3.  Structure and sequence of the human homeobox gene HOX7.

Authors:  J E Hewitt; L N Clark; A Ivens; R Williamson
Journal:  Genomics       Date:  1991-11       Impact factor: 5.736

4.  A nonsense mutation in MSX1 causes Witkop syndrome.

Authors:  D Jumlongras; M Bei; J M Stimson; W F Wang; S R DePalma; C E Seidman; U Felbor; R Maas; J G Seidman; B R Olsen
Journal:  Am J Hum Genet       Date:  2001-05-16       Impact factor: 11.025

5.  Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.

Authors:  M E MacDonald; J P Vonsattel; J Shrinidhi; N N Couropmitree; L A Cupples; E D Bird; J F Gusella; R H Myers
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

6.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

Authors:  L Djoussé; B Knowlton; M Hayden; E W Almqvist; R Brinkman; C Ross; R Margolis; A Rosenblatt; A Durr; C Dode; P J Morrison; A Novelletto; M Frontali; R J A Trent; E McCusker; E Gómez-Tortosa; D Mayo; R Jones; A Zanko; M Nance; R Abramson; O Suchowersky; J Paulsen; M Harrison; Q Yang; L A Cupples; J F Gusella; M E MacDonald; R H Myers
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

7.  The role of MSX1 in human tooth agenesis.

Authors:  A C Lidral; B C Reising
Journal:  J Dent Res       Date:  2002-04       Impact factor: 6.116

Review 8.  The Huntington's disease candidate region exhibits many different haplotypes.

Authors:  M E MacDonald; A Novelletto; C Lin; D Tagle; G Barnes; G Bates; S Taylor; B Allitto; M Altherr; R Myers
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

9.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.

Authors:  Jian-Liang Li; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Alexandra Durr; Catherine Dodé; Patrick J Morrison; Oksana Suchowersky; Christopher A Ross; Russell L Margolis; Adam Rosenblatt; Estrella Gómez-Tortosa; David Mayo Cabrero; Andrea Novelletto; Marina Frontali; Martha Nance; Ronald J A Trent; Elizabeth McCusker; Randi Jones; Jane S Paulsen; Madeline Harrison; Andrea Zanko; Ruth K Abramson; Ana L Russ; Beth Knowlton; Luc Djoussé; Jayalakshmi S Mysore; Suzanne Tariot; Michael F Gusella; Vanessa C Wheeler; Larry D Atwood; L Adrienne Cupples; Marie Saint-Hilaire; Jang-Ho J Cha; Steven M Hersch; Walter J Koroshetz; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Am J Hum Genet       Date:  2003-08-01       Impact factor: 11.025

10.  The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be implicated in Wolf-Hirschhorn syndrome.

Authors:  A Ivens; N Flavin; R Williamson; M Dixon; G Bates; M Buckingham; B Robert
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

View more
  26 in total

1.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

2.  TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

Authors:  Ji-Hyun Lee; Jong-Min Lee; Eliana Marisa Ramos; Tammy Gillis; Jayalakshmi S Mysore; Shotaro Kishikawa; Tiffany Hadzi; Audrey E Hendricks; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Cinzia Gellera; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; G Bernhard Landwehrmeyer; Ira Shoulson; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

3.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

Review 4.  Disease-modifying pathways in neurodegeneration.

Authors:  Steven Finkbeiner; Ana Maria Cuervo; Richard I Morimoto; Paul J Muchowski
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

5.  The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Authors:  Silke Metzger; Peter Bauer; Juergen Tomiuk; Franco Laccone; Stefano Didonato; Cinzia Gellera; Paola Soliveri; Herwig W Lange; Helga Weirich-Schwaiger; Gregor K Wenning; Bela Melegh; Victoria Havasi; Lazlo Balikó; Stefan Wieczorek; Larissa Arning; Jacek Zaremba; Anna Sulek; Dorota Hoffman-Zacharska; A Nazli Basak; Nagehan Ersoy; Jana Zidovska; Vera Kebrdlova; Massimo Pandolfo; Pascale Ribaï; Ludovit Kadasi; Marta Kvasnicova; Bernhard H F Weber; Friedmar Kreuz; Matthias Dose; Manfred Stuhrmann; Olaf Riess
Journal:  Neurogenetics       Date:  2005-12-21       Impact factor: 2.660

6.  Response to Falush: a role for cis-element polymorphisms in HD.

Authors:  Simon C Warby; Henk Visscher; Stefanie Butland; Christopher E Pearson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

7.  Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.

Authors:  Jong-Min Lee; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Eliana Marisa Ramos; Richard H Myers; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Annamaria Griguoli; Stefano Di Donato; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; Marcy E MacDonald; James F Gusella
Journal:  Am J Hum Genet       Date:  2012-03-01       Impact factor: 11.025

8.  Early onset Huntington disease: a neuronal degeneration syndrome.

Authors:  Sara Seneca; Domique Fagnart; Kathelijn Keymolen; Willy Lissens; Daniele Hasaerts; Sara Debulpaep; Brigitte Desprechins; Inge Liebaers; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

9.  Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics.

Authors:  Joseph H Lee; Rong Cheng; Badri Vardarajan; Rafael Lantigua; Dolly Reyes-Dumeyer; Ward Ortmann; Robert R Graham; Tushar Bhangale; Timothy W Behrens; Martin Medrano; Ivonne Z Jiménez-Velázquez; Richard Mayeux
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

10.  Genomewide association study for onset age in Parkinson disease.

Authors:  Jeanne C Latourelle; Nathan Pankratz; Alexandra Dumitriu; Jemma B Wilk; Stefano Goldwurm; Gianni Pezzoli; Claudio B Mariani; Anita L DeStefano; Cheryl Halter; James F Gusella; William C Nichols; Richard H Myers; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.